Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Boyle

Surgery Bend, OR Medical Doctor

NPI 1972581437 CMS profile 89614

2200 Ne Neff Rd Ste 204, Suite 204, Bend, OR 97701

Open in the dashboard

General payments

$618,124

110 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$140,706

2 holdings reported · through program year 2025

Research they led as principal investigator

$9,450 paid to institutions, not to them · program year 2019

Through program year 2025, Edward Boyle of Bend, OR is reported in the CMS Open Payments database as having received $618,124 across 110 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $9,450 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $140,706 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $40 2
2024 General $273 6
2023 General $51,195 9
2022 General $252 4
2021 General $42,960 4
2020 General $250,977 21
2019 General $272,426 64
2025 Ownership $67,348 1
2024 Ownership $73,358 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Boyle
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Edward Boyle were reported at $40. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Edward Boyle Surgery median Middle half National median
2019 $272,426 $253 $82–$1,521 $163
2020 $250,977 $131 $40–$706 $114
2021 $42,960 $168 $50–$904 $132
2022 $252 $224 $76–$1,218 $149
2023 $51,195 $253 $82–$1,255 $160
2024 $273 $279 $90–$1,381 $164
2025 $40 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ClearFlow, Inc. $597,942 56 payments
  2. Medtronic Vascular, Inc. $12,514 25 payments
  3. Boston Scientific Corporation $6,054 7 payments
  4. Medtronic, Inc. $1,482 15 payments
  5. Janssen Pharmaceuticals, Inc $39 2 payments
  6. Pfizer Inc. $34 2 payments
  7. Kedrion Biopharma, Inc. $25 1 payment
  8. Tactile Systems Technology Inc $21 1 payment
  9. E.R. Squibb & Sons, L.L.C. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $308,144 26 payments
  2. Current or prospective ownership or investment interest $293,497 8 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,000 4 payments
  4. Food and Beverage $3,931 67 payments
  5. Travel and Lodging $2,553 5 payments
Products named General payments · program years 2019–2025
  1. PleuraFlow Cardiovascular $539,798 54 payments
  2. Pleuraflow System with FlowGlide $50,511 1 payment
  3. VenaSeal EndoVenous Therapies $12,408 24 payments
  4. PleuraFlow Cardiovascular $7,633 1 payment
  5. General Therapies $5,364 2 payments
  6. VENASEAL EndoVenous Therapies $975 13 payments
  7. VenaSeal EndoVenous Therapies $507 2 payments
  8. General - Therapies $478 1 payment
  9. Varithena Administration Pack $200 3 payments
  10. ClosureFast $106 1 payment
  11. Other $300 15 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$134,263

Medicare's payments for the services billed

Medicare patients

293

Average age 74

Services billed

703

195 women, 98 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 63%
High blood pressure 58%
Ischemic heart disease 26%
Depression 25%
Osteoporosis 25%
Diabetes 20%
Cancer 14%
Atrial fibrillation 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record